← Back to news
S

Seeking Alpha: News

NVent forecasts 15–18% sales growth and $4–$4.15 EPS in 2026 as data center demand accelerates

S

AECOM Q1 2026 Earnings Preview

S

Arch Capital Q4 2025 Earnings Preview

S

Cincinnati Financial Q4 2025 Earnings Preview

S

Danaos Q4 2025 Earnings Preview

S

Brixmor Property Q4 2025 Earnings Preview

S

Chegg Q4 2025 Earnings Preview

S

Amkor Technology Q4 2025 Earnings Preview

S

COPT Defense Properties targets $2.75 FFO per share for 2026 while advancing $450M in pre-leased developments

S

Will exorbitant capex continue to affect tech stocks’ performance?

S

Lockheed Martin declares $3.45 dividend

S

Small-cap stocks with lowest dividend yield grade

S

CVS pharmacies accepting TrumpRx discount cards

S

MGM China Holdings Non-GAAP EPS of $1.60, revenue of $4.6B

S

Venzee Technologies names Hebe Chen as CFO

S

TMX Group GAAP EPS of $0.60, revenue of $457.8M

S

Goldmoney reports Q3 results

S

Verde Clean Fuels to suspend development of Permian Basin project

S

Ryder declares $0.91 dividend

S

Westinghouse Air Brake declares $0.31 dividend

S

Acadia Realty Trust announces key promotions and changes to management team

S

Boise Cascade declares $0.22 dividend

S

Bimergen Energy expects NYSE American uplisting, plans concurrent offering

S

Fed's Daly leans towards more rate cuts amid job market vulnerabilities - report

S

Tech Voices: Huang on AI CapEx, Goldman-Anthropic, China CPU delays

S

Veeco approves merger with Axcelis

S

Regency outlines 3.25%-3.75% same-property NOI growth target while advancing $1B development pipeline

S

U.S. drilling rig count keeps climbing in Baker Hughes survey

S

The Coca-Cola Company climbs for the seventh straight session

S

PepsiCo extends rally for a seventh straight session

S

Plains All American outlines $2.75B EBITDA guidance for 2026 as company executes NGL divestiture, streamlining, and Cactus III integration

S

Dow smashes 50,000 and here’s how all 30 stocks rank according to SA Quant Ratings

S

Roivant signals multiple pivotal trial readouts and accelerates brepocitinib Phase III launch in 2026

S

MarketAxess outlines 8%-9% revenue growth target through 2028 as block trading surges

S

AptarGroup outlines 2026 margin improvement and targets 7%–11% long-term pharma core sales growth amid emergency medicine headwinds

S

Williams weighs buying gas-producing assets to enhance AI energy supply to hyperscalers - Reuters

S

GSK shares uptick for seven consecutive sessions

S

Novartis breaks ground on new R&D center in San Diego

S

Dow tops 50,000 for the first time as the blue-chip rally accelerates

S

Apple plans to update CarPlay to work with third-party AI chatbots: report

S

U.S. consumer credit jumps more than expected in December

B

Catalyst Watch: Crypto swings, FedEx investor event, and Super Bowl bets

B

Tapestry sets record high as Coach delivers --- but can it last?

B

Cboe targets mid- to high single-digit Data Vantage growth and launches event prediction markets amid leadership changes

B

Under Armour outlines $110M operating income target for FY26 as turnaround gains traction

B

Unum projects 8%–12% EPS growth for 2026 as it redefines core metrics and focuses on digital-driven premium expansion

B

Linde downgraded at J.P. Morgan on flat organic growth, weak pricing

S

Envista outlines 2026 guidance with 2%–4% core growth and $1.35–$1.45 adjusted EPS targets amid strong operational momentum

S

Biogen outlines $15.25-$16.25 EPS guidance for 2026 while advancing growth products and pipeline

S

Ameren raises quarterly dividend by 5.6% to $0.75/share

S